Bengt Ullman

1.3k total citations
21 papers, 982 citations indexed

About

Bengt Ullman is a scholar working on Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Bengt Ullman has authored 21 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Surgery. Recurrent topics in Bengt Ullman's work include Heart Failure Treatment and Management (10 papers), Neuropeptides and Animal Physiology (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Bengt Ullman is often cited by papers focused on Heart Failure Treatment and Management (10 papers), Neuropeptides and Animal Physiology (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Bengt Ullman collaborates with scholars based in Sweden, Italy and Finland. Bengt Ullman's co-authors include Jan M. Lundberg, Johan Hulting, Alf Sollevi, Ewa Hägglund, Hans Persson, Michael Melin, Inger Hagerman, Anders Franco‐Cereceda, Mats Frick and David Nathanson and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer and European Heart Journal.

In The Last Decade

Bengt Ullman

21 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bengt Ullman Sweden 15 456 321 251 190 157 21 982
Mark Harbinson United Kingdom 19 564 1.2× 181 0.6× 218 0.9× 62 0.3× 132 0.8× 71 1.3k
Costantino Costantini Brazil 18 1.2k 2.6× 601 1.9× 71 0.3× 145 0.8× 95 0.6× 63 1.7k
Theo E. Meyer United States 21 1.6k 3.5× 399 1.2× 110 0.4× 104 0.5× 105 0.7× 58 1.9k
B L Pentecost United Kingdom 23 1.0k 2.3× 275 0.9× 100 0.4× 236 1.2× 88 0.6× 57 1.6k
M Huelsmann Austria 18 1.2k 2.6× 265 0.8× 153 0.6× 94 0.5× 278 1.8× 48 1.4k
Poul Erik Mortensen Denmark 20 624 1.4× 967 3.0× 121 0.5× 49 0.3× 130 0.8× 43 2.0k
Sanjay Divakaran United States 21 602 1.3× 289 0.9× 78 0.3× 37 0.2× 162 1.0× 78 1.2k
Jun Nejima Japan 14 665 1.5× 132 0.4× 69 0.3× 154 0.8× 341 2.2× 51 1.1k
Dan J. Fintel United States 19 1.3k 2.8× 640 2.0× 339 1.4× 183 1.0× 136 0.9× 38 1.8k
Robert T. Cole United States 14 1.0k 2.2× 485 1.5× 172 0.7× 56 0.3× 206 1.3× 39 1.7k

Countries citing papers authored by Bengt Ullman

Since Specialization
Citations

This map shows the geographic impact of Bengt Ullman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Ullman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Ullman more than expected).

Fields of papers citing papers by Bengt Ullman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Ullman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Ullman. The network helps show where Bengt Ullman may publish in the future.

Co-authorship network of co-authors of Bengt Ullman

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Ullman. A scholar is included among the top collaborators of Bengt Ullman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Ullman. Bengt Ullman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melin, Michael, Ewa Hägglund, Bengt Ullman, Hans Persson, & Inger Hagerman. (2018). Effects of a Tablet Computer on Self-care, Quality of Life, and Knowledge. The Journal of Cardiovascular Nursing. 33(4). 336–343. 34 indexed citations
2.
Nathanson, David, Mats Frick, Bengt Ullman, & Thomas Nyström. (2016). Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure. Diabetology & Metabolic Syndrome. 8(1). 5–5. 16 indexed citations
3.
Rådegran, Göran, Barbro Kjellström, Björn Ekmehag, et al.. (2016). Characteristics and survival of adult Swedish PAH and CTEPH patients 2000–2014. Scandinavian Cardiovascular Journal. 50(4). 243–250. 107 indexed citations
4.
Hägglund, Ewa, Patrik Lyngå, Bengt Ullman, et al.. (2015). Patient-centred home-based management of heart failure. Scandinavian Cardiovascular Journal. 49(4). 193–199. 91 indexed citations
5.
Nathanson, David, Bengt Ullman, Anders Hedman, et al.. (2012). Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety. Diabetologia. 55(4). 926–935. 86 indexed citations
6.
Lauten, Alexander, Annemarie E. Engström, Christian Jung, et al.. (2012). Percutaneous Left-Ventricular Support With the Impella-2.5–Assist Device in Acute Cardiogenic Shock. Circulation Heart Failure. 6(1). 23–30. 234 indexed citations
7.
Bergh, Claes‐Håkan, Bert Andersson, Ulf Dahlström, et al.. (2010). Intravenous Levosimendan vs. Dobutamine in Acute Decompensated Heart Failure Patients on Beta-Blockers. European Journal of Heart Failure. 12(4). 404–410. 57 indexed citations
8.
Skånér, Ylva, Johan Bring, Bengt Ullman, & Lars‐Erik Strender. (2003). Heart failure diagnosis in primary health care: clinical characteristics of problematic patients. A clinical judgement analysis study. BMC Family Practice. 4(1). 12–12. 16 indexed citations
9.
Ulfvarson, Johanna, Johanna Adami, Bengt Ullman, et al.. (2003). Randomized controlled intervention in cardiovascular drug treatment in nursing homes. Pharmacoepidemiology and Drug Safety. 12(7). 589–593. 11 indexed citations
10.
Skånér, Ylva, Johan Bring, Bengt Ullman, & Lars‐Erik Strender. (2000). The use of clinical information in diagnosing chronic heart failure:. Journal of Clinical Epidemiology. 53(11). 1081–1088. 12 indexed citations
11.
Edvardsson, Nils, Heikki V. Huikuri, Göran Kennebäck, A. J. M. Timmermans, & Bengt Ullman. (1996). Antiarrhythmic efficacy by a class III agent with and without betablockade in chronic atrial fibrillation — a double-blind randomized comparison of DI-sotalol, D-sotalol and placebo. Journal of the American College of Cardiology. 27(2). 46–46. 7 indexed citations
12.
Ullman, Bengt, Johan Hulting, & Jan M. Lundberg. (1994). Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. European Heart Journal. 15(4). 454–461. 46 indexed citations
13.
Sigurðsson, Axel F., Karl Swedberg, & Bengt Ullman. (1994). Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure. European Heart Journal. 15(2). 247–254. 19 indexed citations
14.
Ullman, Bengt, Kaj Lindvall, Jan M. Lundberg, Axel F. Sigurðsson, & Karl Swedberg. (1994). Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure. Clinical Physiology. 14(2). 123–134. 15 indexed citations
15.
Ullman, Bengt, Mats Jensen‐Urstad, Johan Hulting, & Jan M. Lundberg. (1993). Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure. Clinical Physiology. 13(4). 409–418. 12 indexed citations
16.
Berg, Anders, et al.. (1991). considerations for the treatment of Ethylene glycol poisoning Based On Analysis Of Two Cases. Journal of Toxicology Clinical Toxicology. 29(2). 231–240. 21 indexed citations
17.
Ullman, Bengt, Anders Franco-Cereceda, Johan Hulting, Jan M. Lundberg, & Alf Sollevi. (1990). Elevation of plasma neuropeptide Y‐like immunoreactivity and noradrenaline during myocardial ischaemia in man. Journal of Internal Medicine. 228(6). 583–589. 37 indexed citations
18.
Hulting, Johan, Alf Sollevi, Bengt Ullman, Anders Franco‐Cereceda, & Jan M. Lundberg. (1990). Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure. Cardiovascular Research. 24(2). 102–108. 90 indexed citations
19.
Ullman, Bengt, et al.. (1989). [Treatment of various stages of ethylene glycol poisoning].. PubMed. 86(13). 1183–5. 1 indexed citations
20.
Christensson, Birger, et al.. (1986). Cell proliferation and DNA content in non-hodgkin' s lymphoma: Flow cytometry in relation to lymphoma classification. Cancer. 58(6). 1295–1304. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026